The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes
Recruiting
Phase 3
Interventional Study
Newborn Health
Multiple Micronutrient Deficiencies During Pregnancy
Nutrition During Pregnancy
Adaptive Trial
Postnatal Growth
Neurodevelopment Outcome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 15 – 49
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 3,000 (estimated)
- Sponsor
- Aga Khan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial aims to learn if MMS Plus improves infant health compared to standard MMS during pregnancy and the postnatal period in women living in peri-urban areas of Karachi, Pakistan. It will also evaluate how MMS Plus affects infant growth during the first 6 months of life.
The main questions it aims to answer are:
1. Does MMS Plus during pregnancy reduce the risk of poor infant outco…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Antenatal Phase::
Inclusion Criteria:
* Gestational age confirmed by ultrasound to be 8-14 weeks
* Singleton and viable fetus on ultrasound
* A resident of the catchment area for at least the last six months
* Plans to stay within the catchment area during the pregnancy duration, during delivery a…
Contacts